ClinConnect ClinConnect Logo
Search / Trial NCT06282666

Lumbar ESPB in Hip Replacement Surgery

Launched by MEDICAL UNIVERSITY OF LUBLIN · Feb 20, 2024

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Erector Spinae Plane Block Epidural Analgesia Quality Of Recovery Patient Controlled Analgesia Timed Up And Go Test Visual Analog Scale Neuropathic Pain Symptom Inventory Lovett Scale Spinal Anesthesia

ClinConnect Summary

This clinical trial is looking at two different ways to manage pain for patients undergoing hip replacement surgery. One method is called a continuous erector spinae plane block (ESPB), and the other is a continuous epidural analgesia. The goal is to see which method helps patients feel less pain after surgery, allows them to recover better, and improves their ability to walk and regain muscle strength. The study will also check how much pain patients feel months after leaving the hospital.

To participate in this trial, you need to be having a hip replacement surgery due to coxarthrosis, and you must be able to use a patient-controlled analgesia (PCA) pump, which lets you manage your own pain medication. You should also have access to a phone for follow-up. However, if you are taking certain pain medications for other conditions, have active cancer, dementia, or other significant mental health issues, you may not be eligible. If you decide to join, you can expect to be closely monitored for your pain levels and recovery progress, helping to find the best pain management option for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • primary hip replacement surgery due to coxarthrosis
  • anesthetized with spinal technique
  • able to use PCA pump
  • having access to phone
  • Exclusion Criteria:
  • patients taking painkillers not related to coxarthrosis;
  • having active cancer,
  • dementia or challenging contact with the patient;
  • suffering from depression or other psychiatric disorders that required antidepressant treatment;
  • consuming alcohol or recreational drug addiction;
  • contraindications to the regional block.

About Medical University Of Lublin

The Medical University of Lublin is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a vibrant environment for medical and scientific inquiry, aiming to improve patient outcomes and contribute to the broader medical community. Its commitment to ethical research practices and patient safety ensures that all clinical trials conducted under its auspices adhere to the highest standards of scientific rigor and regulatory compliance. The Medical University of Lublin is positioned at the forefront of medical education and research in Poland, making significant contributions to the fields of medicine, pharmacy, and health sciences.

Locations

Lublin, , Poland

Patients applied

0 patients applied

Trial Officials

Paweł Piwowarczyk, M.D., Ph.D.

Study Chair

Medical University of Lublin

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported